Rhinoscleroma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Rhinoscleroma is a chronic granulomatous bacterial disease of the nose that can sometimes infect the upper respiratory tract. It most commonly affects the nasal cavity—the nose is involved in 95-100 per cent of cases—however, it can also affect the nasopharynx, larynx, trachea, and bronchi.

Slightly more females than males are affected and patients are usually 10 to 30 years of age. Rhinoscleroma is considered a tropical disease and is mostly endemic to Africa and Central America, less common in the United States.

Rhinoscleroma is not lethal in nature and is responsive to Tetracycline or Ciprofloxacin. However, if left untreated the disease can lead to sepsis, hemorrhage or other chronic conditions that can be fatal.

Rhinoscleroma is not lethal in nature and is responsive to Tetracycline or Ciprofloxacin.

Template:WH Template:WS